Related Experiment Video
Updated: Dec 8, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Different mother and daughter manifestations due to very high cholesterol-containing lipoproteins
1University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. robert_block@urmc.rochester.edu.
Insights
Familial hypercholesterolemia (FH) increases atherosclerotic cardiovascular disease (ASCVD) risk. Elevated lipoprotein(a) (Lp(a)) may worsen this risk, highlighting the need for Lp(a) screening in FH families.
Area of Science:
- Genetics
- Cardiology
- Biochemistry
Background:
- Familial hypercholesterolemia (FH) is an inherited disorder impacting LDL cholesterol metabolism.
- FH significantly elevates the risk of premature atherosclerotic cardiovascular disease (ASCVD).
- Elevated lipoprotein(a) (Lp(a)) is an emerging risk factor for ASCVD.
Observation:
- A case series involving two Familial hypercholesterolemia patients, a mother and daughter, was analyzed.
- The daughter exhibited a greater atherosclerotic cardiovascular disease burden compared to her mother.
- This difference was attributed to the daughter's significantly higher lipoprotein(a) levels.
Findings:
- Elevated lipoprotein(a) (Lp(a)) levels in Familial hypercholesterolemia (FH) patients correlate with increased atherosclerotic cardiovascular disease (ASCVD) risk.
- Genetic predisposition and lipid profiles, including Lp(a), contribute to ASCVD severity in FH.
Implications:
- Incorporating lipoprotein(a) (Lp(a)) testing into cascade screening for Familial hypercholesterolemia (FH) is crucial.
- Early identification of elevated Lp(a) in FH relatives can guide proactive ASCVD risk management.
- Personalized risk assessment in FH should consider both LDL-C and Lp(a) levels.
Objective:
Familial hypercholesterolemia (FH) is an autosomal codominant genetic disorder associated with defective hepatic uptake of circulating low-density lipoproteins (LDL), which can lead to premature atherosclerotic cardiovascular disease (ASCVD). Evidence suggests elevated lipoprotein(a) (Lp(a)) levels in FH patients may also increase their ASCVD risk. We present a case series of 2 FH patients where a daughter has a higher ASCVD burden than her mother due to the daughter having elevated Lp(a). This underscores the importance of including Lp(a) in cascade lipid screening in FH patients and their first-degree relatives.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Inflammation
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis I: Introduction

